Dietary therapies safe and efficient for treating drug-resistant epilepsy
February 7th 2023While treatment discontinuation because of adverse events was more likely when taking dietary therapies for treating childhood drug-resistant epilepsy, reduction of seizures and seizure freedom were significantly more common.
Cleveland Clinic reexamines syphilis testing strategies after rise in cases
February 7th 2023After observing an increase in the rate of syphilis cases, the Cleveland Clinic Ob/Gyn & Women’s Health Institute has partnered with the Center for Pediatric Infectious Diseases to evaluate the effectiveness of current testing strategies.
Air pollution in urban areas linked to asthma, inflammatory responses in children
January 31st 2023The specific mechanisms involved in associations between air pollution and respiratory illness without viral infection are not understood, especially compared with those of respiratory viruses and asthma exacerbation.
FDA approves Odactra for treating pediatric house dust mite-induced allergic rhinitis
January 26th 2023Odactra (House Dust Mite Allergen Extract; ALK) has received approval from the US Food and Drug Administration for use in patients aged 12 to 17 years with house dust mite-induced allergic rhinitis.